A medication surveillance system model to improve patient safety: A national veterans study of cyclooxygenase 2 inhibitors and risks of stroke or myocardial infarction
JavaScript is disabled for your browser. Some features of this site may not work without it.
A medication surveillance system model to improve patient safety: A national veterans study of cyclooxygenase 2 inhibitors and risks of stroke or myocardial infarction